News Agency
The Times

  • Written by PR Newswire
Yuyu Pharma CEO Robert Wonsang Yu Launches "Robert's YUniverse" Podcast

SEOUL, South Korea, Sept. 9, 2026 /PRNewswire/ -- Robert Wonsang Yu, CEO of Yuyu Pharma, has launched "Robert's YUniverse", a new podcast series featuring conversations with guests from across culture, business and animal health.

Hosted by Robert Wonsang Yu, the podcast explores subjects including Korean culture, Korean cuisine and global business insights. The series also places a particular focus on pet health, with discussions on topics such as veterinary biotechnology and cat wellness.

Early episodes feature interviews with international experts from the animal health industry, academia and the veterinary field. Conversations focus on recent research findings, emerging technologies and practical ideas expected to shape the future of animal health.

"I want 'Robert's YUniverse' to be a place where I can meet interesting people from a wide range of fields, ask questions and share what I learn," said Robert Wonsang Yu, CEO of Yuyu Pharma. "The show will go beyond pharmaceuticals and biotechnology to explore Korea and Asia, as well as food, travel and pets."

About Yuyu Pharma

Founded in 1941, Yuyu Pharma (KRX: 000220) is a Korea-based healthcare company focused on pharmaceuticals, medical devices, and health supplements that improve quality of life. As part of its global growth strategy, the company invests in early-stage and high-growth innovators across biotechnology, sustainability, and animal health through Yuyu Venture Studio.

Read more http://www.prnasia.com/story/archive/5043631_CN43631_0

How Can Businesses Reduce the Risk of Commercial Litigation?

Commercial disputes often begin with a misunderstanding, an unclear contract or a delayed response to a growing problem. Seeking early advice from Litigation Lawyers Sydney with PCL lawyers can help businesses trust and identify legal risks, clarify obligations and create a strategy... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion